Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 17-Sep-24 5:52 PM View:  | Morrison Scott W Director | Tarsus Pharmaceuticals, Inc. (TARS) | 15-Sep-24 | Option Exercise | 1,333 | -- | -- | 28% 4.68K to 6.02K | |
| 14-Aug-24 4:34 PM View: | Link William J Phd Director | Tarsus Pharmaceuticals, Inc. (TARS) | 12-Aug-24 | Acquisition (other) | 27,116 | -- | -- | 10% 260.32K to 287.44K | |
| 14-Aug-24 4:34 PM View: | Link William J Phd Director | Tarsus Pharmaceuticals, Inc. (TARS) | 12-Aug-24 | Sale | 35,000 | $26.08 | $912,961.00 | (16%) 212.54K to 177.54K | |
| 14-Aug-24 4:34 PM View: | Link William J Phd Director | Tarsus Pharmaceuticals, Inc. (TARS) | 12-Aug-24 | Disposition (other) | 74,892 | -- | -- | (26%) 287.44K to 212.54K | |
| 14-Aug-24 4:34 PM View: | Link William J Phd Director | Tarsus Pharmaceuticals, Inc. (TARS) | 12-Aug-24 | Acquisition (other) | 10,446 | -- | -- | 4% 249.87K to 260.32K | |
| 25-Jun-24 6:23 PM View: | Morrison Scott W Director | Tarsus Pharmaceuticals, Inc. (TARS) | 24-Jun-24 | Option Exercise | 3,350 | -- | -- | 251% 1.33K to 4.68K | |
| 25-Jun-24 6:24 PM View: | Lin Elizabeth Yeu Director | Tarsus Pharmaceuticals, Inc. (TARS) | 24-Jun-24 | Option Exercise | 3,350 | -- | -- | 11% 29.91K to 33.26K | |
| 25-Jun-24 6:22 PM View: | Chaudhuri Bhaskar Director | Tarsus Pharmaceuticals, Inc. (TARS) | 24-Jun-24 | Option Exercise | 3,350 | -- | -- | 167% 2.0K to 5.35K | |
| 25-Jun-24 6:21 PM View: | Yarno Wendy L Director | Tarsus Pharmaceuticals, Inc. (TARS) | 24-Jun-24 | Option Exercise | 3,350 | -- | -- | 48% 7.0K to 10.35K | |
| 25-Jun-24 6:25 PM View: | Link William J Phd Director | Tarsus Pharmaceuticals, Inc. (TARS) | 24-Jun-24 | Option Exercise | 3,350 | -- | -- | 2% 136.63K to 139.98K | |
| 25-Jun-24 6:26 PM View: | Goldberg Andrew D. Director | Tarsus Pharmaceuticals, Inc. (TARS) | 24-Jun-24 | Option Exercise | 3,350 | -- | -- | 112% 3.0K to 6.35K | |
| 25-Jun-24 6:26 PM View: | Crane Rosemary A Director | Tarsus Pharmaceuticals, Inc. (TARS) | 24-Jun-24 | Option Exercise | 3,350 | -- | -- | 167% 2.0K to 5.35K | |
| 19-Mar-24 7:08 PM View: | Mottiwala Aziz Chief Commercial Officer | Tarsus Pharmaceuticals, Inc. (TARS) | 18-Mar-24 | Option Sale | 4,766 | $30.60 | $145,840.00 | (8%) 58.84K to 54.08K | |
| 19-Mar-24 7:05 PM View: | Azamian Bobak R. President/CEO and Board Chair Director | Tarsus Pharmaceuticals, Inc. (TARS) | 18-Mar-24 | Option Sale | 10,415 | $30.60 | $318,699.00 | (1%) 866.98K to 856.56K | |
| 19-Mar-24 7:05 PM View: | Wahl Bryan General Counsel | Tarsus Pharmaceuticals, Inc. (TARS) | 18-Mar-24 | Option Sale | 4,436 | $30.60 | $135,742.00 | (10%) 45.39K to 40.95K | |
| 19-Mar-24 7:04 PM View: | Whitfield Dianne C. Chief Human Resources Officer | Tarsus Pharmaceuticals, Inc. (TARS) | 18-Mar-24 | Option Sale | 4,314 | $30.60 | $132,008.00 | (11%) 38.49K to 34.18K | |
| 19-Mar-24 7:03 PM View: | Neervannan Seshadri Chief Operating Officer | Tarsus Pharmaceuticals, Inc. (TARS) | 18-Mar-24 | Option Sale | 4,879 | $30.60 | $149,297.00 | (7%) 69.65K to 64.77K | |
| 19-Mar-24 7:04 PM View: | Whitfield Dianne C. Chief Human Resources Officer | Tarsus Pharmaceuticals, Inc. (TARS) | 15-Mar-24 | Option Exercise | 11,711 | -- | -- | 44% 26.78K to 38.49K | |
| 19-Mar-24 7:03 PM View: | Neervannan Seshadri Chief Operating Officer | Tarsus Pharmaceuticals, Inc. (TARS) | 15-Mar-24 | Option Exercise | 13,245 | -- | -- | 23% 56.4K to 69.65K | |
| 19-Mar-24 7:05 PM View: | Wahl Bryan General Counsel | Tarsus Pharmaceuticals, Inc. (TARS) | 15-Mar-24 | Option Exercise | 12,038 | -- | -- | 36% 33.35K to 45.39K | |
| 19-Mar-24 7:08 PM View: | Mottiwala Aziz Chief Commercial Officer | Tarsus Pharmaceuticals, Inc. (TARS) | 15-Mar-24 | Option Exercise | 12,938 | -- | -- | 28% 45.9K to 58.84K | |
| 19-Mar-24 7:05 PM View: | Azamian Bobak R. President/CEO and Board Chair Director | Tarsus Pharmaceuticals, Inc. (TARS) | 15-Mar-24 | Option Exercise | 28,274 | -- | -- | 3% 838.7K to 866.98K | |
| 29-Dec-23 5:08 PM View: | Azamian Bobak R. President/CEO and Board Chair Director | Tarsus Pharmaceuticals, Inc. (TARS) | 27-Dec-23 | Market Sale (Planned) | 8,000 | $20.22 | $161,760.00 | (< 1%) 846.7K to 838.7K | (10%) |
| 22-Dec-23 5:32 PM View: | Trevejo Jose M. CHIEF MEDICAL OFFICER | Tarsus Pharmaceuticals, Inc. (TARS) | 20-Dec-23 | Market Sale (Planned) | 2,252 | $20.00 | $45,040.00 | (50%) 4.5K to 2.25K | (11%) |
| 22-Dec-23 5:30 PM View: | Azamian Bobak R. President/CEO and Board Chair Director | Tarsus Pharmaceuticals, Inc. (TARS) | 20-Dec-23 | Market Sale (Planned) | 40,000 | $20.27 | $810,623.00 | (5%) 886.7K to 846.7K | (9%) |
| 19-Dec-23 6:30 PM View: | Goldberg Andrew D. Director | Tarsus Pharmaceuticals, Inc. (TARS) | 15-Dec-23 | Private Purchase | 1,000 | $18.96 | $18,960.00 | 50% 2.0K to 3.0K | |
| 05-Dec-23 6:27 PM View: | Yarno Wendy L Director | Tarsus Pharmaceuticals, Inc. (TARS) | 02-Dec-23 | Option Exercise | 5,000 | -- | -- | 250% 2.0K to 7.0K | |
| 01-Dec-23 4:55 PM View: | Wahl Bryan General Counsel | Tarsus Pharmaceuticals, Inc. (TARS) | 30-Nov-23 | Option Sale | 8,356 | $16.31 | $136,286.00 | (21%) 40.32K to 31.97K | |
| 01-Dec-23 4:58 PM View: | Whitfield Dianne C. Chief Human Resources Officer | Tarsus Pharmaceuticals, Inc. (TARS) | 30-Nov-23 | Option Sale | 8,355 | $16.31 | $136,270.00 | (24%) 35.14K to 26.78K | |
| 01-Dec-23 4:55 PM View: | Wahl Bryan General Counsel | Tarsus Pharmaceuticals, Inc. (TARS) | 29-Nov-23 | Option Exercise | 23,920 | -- | -- | 146% 16.4K to 40.32K | |
| 01-Dec-23 4:58 PM View: | Whitfield Dianne C. Chief Human Resources Officer | Tarsus Pharmaceuticals, Inc. (TARS) | 29-Nov-23 | Option Exercise | 23,920 | -- | -- | 213% 11.22K to 35.14K | |
| 17-Nov-23 4:50 PM View: | Azamian Bobak R. President/CEO and Board Chair Director | Tarsus Pharmaceuticals, Inc. (TARS) | 15-Nov-23 | Sale (Planned) | 8,000 | $18.37 | $146,933.00 | (< 1%) 894.7K to 886.7K | |
| 20-Oct-23 4:41 PM View: | Azamian Bobak R. President/CEO and Board Chair Director | Tarsus Pharmaceuticals, Inc. (TARS) | 18-Oct-23 | Sale (Planned) | 8,000 | $13.24 | $105,920.00 | (< 1%) 902.7K to 894.7K | |
| 06-Oct-23 5:21 PM View: | Trevejo Jose M. CHIEF MEDICAL OFFICER | Tarsus Pharmaceuticals, Inc. (TARS) | 05-Oct-23 | Sale (Planned) | 1,604 | $18.00 | $28,872.00 | (26%) 6.11K to 4.5K | |
| 22-Sep-23 5:30 PM View: | Azamian Bobak R. President/CEO and Board Chair Director | Tarsus Pharmaceuticals, Inc. (TARS) | 20-Sep-23 | Sale (Planned) | 8,000 | $17.21 | $137,680.00 | (< 1%) 910.7K to 902.7K | |
| 19-Sep-23 4:25 PM View: | Morrison Scott W Director | Tarsus Pharmaceuticals, Inc. (TARS) | 15-Sep-23 | Option Exercise | 1,333 | -- | -- | 100% 0 to 1.33K | |
| 25-Aug-23 5:12 PM View: | Azamian Bobak R. President/CEO and Board Chair Director | Tarsus Pharmaceuticals, Inc. (TARS) | 23-Aug-23 | Sale (Planned) | 8,000 | $17.23 | $137,840.00 | (< 1%) 918.7K to 910.7K | |
| 17-Aug-23 6:02 PM View: | Lin Elizabeth Yeu Director | Tarsus Pharmaceuticals, Inc. (TARS) | 15-Aug-23 | Private Purchase | 9,506 | $16.80 | $159,701.00 | 47% 20.4K to 29.91K | |
| 21-Jul-23 5:42 PM View: | Azamian Bobak R. President/CEO and Board Chair Director | Tarsus Pharmaceuticals, Inc. (TARS) | 19-Jul-23 | Market Sale (Planned) | 103,900 | $20.01 | $2,078,980.00 | (10%) 1.02M to 918.7K | (11%) |
| 21-Jul-23 5:46 PM View: | Mottiwala Aziz Chief Commercial Officer | Tarsus Pharmaceuticals, Inc. (TARS) | 19-Jul-23 | Market Sale (Planned) | 2,400 | $20.05 | $48,120.00 | (5%) 48.21K to 45.81K | (11%) |
| 14-Jul-23 4:40 PM View: | Azamian Bobak R. President/CEO and Board Chair Director | Tarsus Pharmaceuticals, Inc. (TARS) | 12-Jul-23 | Sale (Planned) | 9,000 | $17.35 | $156,150.00 | (< 1%) 1.03M to 1.02M | |
| 23-Jun-23 4:29 PM View: | Azamian Bobak R. President/CEO and Board Chair Director | Tarsus Pharmaceuticals, Inc. (TARS) | 21-Jun-23 | Sale (Planned) | 8,000 | $18.63 | $149,040.00 | (< 1%) 1.04M to 1.03M | |
| 21-Jun-23 6:18 PM View: | Goldberg Andrew D. Director | Tarsus Pharmaceuticals, Inc. (TARS) | 16-Jun-23 | Option Exercise | 2,000 | -- | -- | 100% 0 to 2.0K | |
| 21-Jun-23 6:25 PM View: | Chaudhuri Bhaskar Director | Tarsus Pharmaceuticals, Inc. (TARS) | 16-Jun-23 | Option Exercise | 2,000 | -- | -- | 100% 0 to 2.0K | |
| 21-Jun-23 6:08 PM View: | Link William J Phd Director | Tarsus Pharmaceuticals, Inc. (TARS) | 16-Jun-23 | Option Exercise | 2,000 | -- | -- | 1% 134.63K to 136.63K | |
| 21-Jun-23 6:27 PM View: | Crane Rosemary A Director | Tarsus Pharmaceuticals, Inc. (TARS) | 16-Jun-23 | Option Exercise | 2,000 | -- | -- | 100% 0 to 2.0K | |
| 21-Jun-23 6:14 PM View: | Lin Elizabeth Yeu Director | Tarsus Pharmaceuticals, Inc. (TARS) | 16-Jun-23 | Option Exercise | 2,000 | -- | -- | 11% 18.4K to 20.4K | |
| 21-Jun-23 6:21 PM View: | Yarno Wendy L Director | Tarsus Pharmaceuticals, Inc. (TARS) | 16-Jun-23 | Option Exercise | 2,000 | -- | -- | 100% 0 to 2.0K | |
| 12-Jun-23 5:25 PM View: | Mottiwala Aziz Chief Commercial Officer | Tarsus Pharmaceuticals, Inc. (TARS) | 08-Jun-23 | Market Sale (Planned) | 100 | $20.00 | $2,000.00 | (< 1%) 48.19K to 48.09K | (11%) |
| 12-Jun-23 5:40 PM View: | Azamian Bobak R. President/CEO and Board Chair Director | Tarsus Pharmaceuticals, Inc. (TARS) | 08-Jun-23 | Market Sale (Planned) | 3,100 | $20.01 | $62,031.00 | (< 1%) 1.04M to 1.04M | (11%) |
